GE HealthCare Technologies Inc. (GEHC)

Market Cap	31.17B
Revenue (ttm)	19.67B
Net Income (ttm)	1.99B
Shares Out	457.84M
EPS (ttm)	4.34
PE Ratio	15.69
Forward PE	14.53
Dividend	$0.14 (0.21%)
Ex-Dividend Date	Apr 25, 2025

Volume	5,692,078
Open	67.88
Previous Close	68.07
Day's Range	67.11 - 68.54
52-Week Range	57.65 - 94.80
Beta	1.31
Analysts	Buy
Price Target	97.73 (+43.53%)
Earnings Date	Apr 30, 2025

About GEHC

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1892
• Employees: 53,000
• Stock Exchange: NASDAQ
• Ticker Symbol: GEHC
• Website: https://www.gehealthcare.com

Financial Performance

In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.

Analyst Forecast

According to 11 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $97.73, which is an increase of 43.53% from the latest price.

Price Target

$97.73

(43.53% upside)

Analyst Consensus: Buy